JB Pharma has for the first time supplied lozenges in Europe through partnerships with Kenvue (formerly J&J’s consumer healthcare division) and Krka, said Nikhil Chopra, JB Pharma Chief Executive Officer and Whole-time Director.
The company expects to supply lozenges in the United States by September/October, through its partnership with P&G, Chopra told businessline, of the “small but good start”. Lozenges account for 80 percent of JB Pharma’s contract development and manufacturing (CDM) business.
The CDM business clocked $50 million revenues, and the client’s branded lozenges are in the immunity space (Zinc/vitamin C and…
